- Home
- GS vs TMO Comparison
GS vs TMO Comparison
Compare GS & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GS
- TMO
- Stock Information
- Founded
- GS 1869
- TMO 1956
- Country
- GS United States
- TMO United States
- Employees
- GS N/A
- TMO N/A
- Industry
- GS Investment Bankers/Brokers/Service
- TMO Industrial Machinery/Components
- Sector
- GS Finance
- TMO Industrials
- Exchange
- GS Nasdaq
- TMO Nasdaq
- Market Cap
- GS 182.7B
- TMO 211.0B
- IPO Year
- GS 1999
- TMO N/A
- Fundamental
- Price
- GS $566.21
- TMO $523.89
- Analyst Decision
- GS Buy
- TMO Strong Buy
- Analyst Count
- GS 17
- TMO 18
- Target Price
- GS $559.75
- TMO $650.72
- AVG Volume (30 Days)
- GS 2.0M
- TMO 2.2M
- Earning Date
- GS 01-15-2025
- TMO 01-29-2025
- Dividend Yield
- GS 2.12%
- TMO 0.30%
- EPS Growth
- GS 64.86
- TMO 4.56
- EPS
- GS 34.06
- TMO 15.95
- Revenue
- GS $49,387,000,000.00
- TMO $42,370,000,000.00
- Revenue This Year
- GS $17.81
- TMO $0.86
- Revenue Next Year
- GS $5.55
- TMO $5.39
- P/E Ratio
- GS $16.62
- TMO $32.85
- Revenue Growth
- GS 11.97
- TMO N/A
- 52 Week Low
- GS $372.07
- TMO $493.30
- 52 Week High
- GS $612.73
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- GS 43.60
- TMO 44.94
- Support Level
- GS $544.49
- TMO $508.86
- Resistance Level
- GS $596.32
- TMO $535.94
- Average True Range (ATR)
- GS 11.93
- TMO 10.26
- MACD
- GS -6.71
- TMO 0.76
- Stochastic Oscillator
- GS 32.45
- TMO 44.81
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).